Broke even in Q2, but recovery of non-COVID portfolios has been rapid in Q3: Anand K Anand K, CEO, SRL Diagnostics narrates how COVID-19 impacted revenues but he is optimistic that their FY 20-21 revenues will be…
Tissue diagnostics: Widening the horizon in onco care Having evolved over the last two decades, the tissue diagnostics sector is going to gain new heights backed by rising incidence of…
Current and future perspectives in tissue diagnostics within India: Sanjeev Nair, CEO, HISTOXPERT |… Dx Summit 2019 | India's Largest Diagnostic Business Conclave | 22-23 February 2019 | Novotel Airport, Hyderabad
